https://www.selleckchem.com/
target of 1,100-1,300 patients per full-time primary care clinician is roughly appropriate, though this should be interpreted with caution given the limitations. Respiratory syncytial virus (RSV) and influenza cause significant disease burden in older adults. Overlapping RSV and influenza seasonality presents the opportunity to coadminister vaccines for both infections. This study assessed coadministration of the investigational vaccine, Ad26.RSV.preF, an adenovirus serotype 26 (Ad26) vector encoding RSV F protein stabilized in its prefusion conformation (p